Beneficial effect of roxadustat on early posttransplant anemia and iron utilization in kidney transplant recipients: a retrospective comparative cohort study

BACKGROUND: Although posttransplant anemia (PTA) is a common complication after kidney transplant, it has not been thoroughly evaluated for appropriate treatment. Roxadustat can stimulate erythropoiesis by increasing erythropoietin (EPO) production and improving the utilization of iron. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Hu, Shu-Meng, Li, Ya-Mei, Ciancio, Gaetano, Tadros, Nicholas N., Tao, Ye, Bai, Yang-Juan, Shi, Yun-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843359/
https://www.ncbi.nlm.nih.gov/pubmed/36660711
http://dx.doi.org/10.21037/atm-22-5897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843359/
https://www.ncbi.nlm.nih.gov/pubmed/36660711
http://dx.doi.org/10.21037/atm-22-5897

Ejemplares similares